SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-22-013952
Filing Date
2022-08-25
Accepted
2022-08-25 08:00:22
Documents
5
Period of Report
2022-10-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20221005xdef14a.htm DEF 14A 184871
2 GRAPHIC tmb-20221005xdef14a005.jpg GRAPHIC 95864
3 GRAPHIC tmb-20221005xdef14a003.jpg GRAPHIC 85070
4 GRAPHIC tmb-20221005xdef14a002.jpg GRAPHIC 101616
5 GRAPHIC tmb-20221005xdef14a004.jpg GRAPHIC 153041
  Complete submission text file 0001558370-22-013952.txt   786528
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-38247 | Film No.: 221193024
SIC: 2834 Pharmaceutical Preparations